Compare Novartis AG (NVS) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs RLX Technology Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while RLX Technology Inc trades at $1.98 (market cap $2.42B). The key difference: Novartis AG is far larger — about 122.1× RLX Technology Inc's market cap, and RLX Technology Inc pays the higher dividend (5.05%). Which is the better fit depends on your goals.
| NVS | RLX | |
|---|---|---|
Market Cap | $295.37B | $2.42B |
Sector | Health | Technology |
52-Week High | $168.62 | $2.73 |
52-Week Low | $119.31 | $1.79 |
Enterprise Value | $336.69B | $1.04B |
Dividend Yield | 3.07% | 5.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
